Cell Therapeutics (CTIC) Posts Narrower Q1 Loss of 9c/Share

April 20, 2012 6:44 AM
Cell Therapeutics Inc. (NASDAQ: CTIC) reported Q1 EPS of ($0.09), $0.01 better than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Cell Therapeutics Inc. (CTIC) click here.

Categories

Earnings